business_development

Cambridge, Mass. – November 05, 2026 -- Harbour BioMed (HKEX: 02142) has appointed Vivian Feng, a business development executive with over 16 years of biotech and pharma experience who most recently led BD at Fosun Pharma, as Senior Vice President, Head of External Collaboration. Feng will be based in Shanghai and report directly to Chief Strategy Officer Mike Patten.

Feng will oversee business development and licensing across the HBM Group

Feng will lead the antibody developer's external collaboration strategy, linking its platform, pipeline and innovation capabilities with outside partners. She will also foster synergy and information flow across HBM Group entities and its NewCos.

Her mandate includes building the processes and team capabilities for a scalable, risk-controlled external collaboration function.

Tampa, FL and London – October 29, 2026 -- Akari Therapeutics (Nasdaq: AKTX) has appointed Vatnak Vat-Ho as Chief Business Officer, adding an executive who has held senior roles in oncology transactions totaling more than $25 billion in aggregate value.

Vat-Ho will run corporate strategy, partnering, licensing and investor engagement

Vat-Ho will lead corporate and business development at the oncology biotech, which is developing antibody drug conjugates (ADCs) built on a novel RNA splicing-disrupting payload called PH1. His remit covers corporate strategy, partnering and licensing, and investor engagement as the company advances its lead TROP2-targeted ADC, AKTX-101, toward the clinic.

He brings more than 20 years of experience across oncology business development, biopharmaceutical strategy, equity research and healthcare investing. His transaction record involves Pfizer, Exelixis, BioNTech, Merck KGaA, Roivant and Roche/Genentech.

Washington – September 12, 2026 -- Rapidan Energy Group has appointed James McLennan as Senior Vice President for Business Development, tasking him with leading growth across the firm's energy market, policy, and geopolitical research and data services.

McLennan brings two decades of energy research sales experience to Rapidan

McLennan spent 17 years at Wood Mackenzie leading global commercial teams serving the energy and financial services sectors. He also held senior leadership roles at IHS Markit and S&P Global before joining Rapidan.

Rapidan CEO cites McLennan's commercial track record as key hire rationale

"James will focus on building long-term, trusted relationships across our client base while leading our sales and customer-success functions to support the firm's continued growth," said Scott Modell, CEO of Rapidan Energy Group.